Despite significant advances in treatment of primary tumors, metastatic cancer remains a leading cause of solid cancer mortality. HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumor dormancy.

Biotechnology

HiberCell

HiberCell's headquarters in New York, NY, United States

Beth Johnson

Michael Danielson

Ari Nowacek

Nandita Bose

José Iglesias

Eric Lightcap

Haiguo Wu

Kyle Michel

Hui Wang

Ben Harrison

Jeremy Drees

Alexander Conte

Kathryn Bieging-Rolett, PhD

Julio Aguirre-Ghiso

Christoph Klein

Cindy Jacobs

Jim Sullivan

Colin Goddard

Lisa M. Coussens

Philip Rowlands

Gregory L. Beatty

Steven Gillis

Ronald Wek

Ruggero De Maria

Description

People (3)

Crissy Dudgeon

Julio Aguirre-Ghiso

Feven Tameire, PhD

Jobs